NanoViricides(NNVC)

Search documents
NanoViricides says antiviral NV-387 may reduce cancer resurgence risk tied to viral infections
Proactiveinvestors NA· 2025-08-18 13:35
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
NanoViricides says antiviral candidate NV-387 could address global measles surge
Proactiveinvestors NA· 2025-07-30 13:33
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights across sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
NanoViricides eyes revenue opportunities with broad-spectrum antiviral NV-387
Proactiveinvestors NA· 2025-07-23 13:37
About this content Proactive has always been a forward looking and enthusiastic technology adopter. Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows. Proactive news team spans the world's key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. We are experts in medium and small-cap markets, we also keep our community up to ...
NanoViricides says lead antiviral boosted survival in measles-infected mice
Proactiveinvestors NA· 2025-07-21 12:36
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
NanoViricides says MPox drug candidate NV-387 poised for Phase II trial as WHO extends global health emergency
Proactiveinvestors NA· 2025-07-16 13:16
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
NanoViricides positioned at forefront of Mpox treatment efforts, says Zacks
Proactiveinvestors NA· 2025-07-15 16:29
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
NanoViricides nears completion of clinical trial design for MPox treatment
Proactiveinvestors NA· 2025-07-14 12:52
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced news journalists who produce independent content across various financial markets [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content delivered includes insights across sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for its forward-looking approach and enthusiastic adoption of technology to enhance workflows [4] - The company utilizes automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]
NanoViricides advances antiviral candidate NV-387 into Phase 2 trials for Mpox
Proactiveinvestors NA· 2025-07-02 12:36
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
NanoViricides touts antiviral NV-387 as tool against new COVID variant
Proactiveinvestors NA· 2025-06-18 12:36
Group 1 - Proactive is a leading provider of timely, multimedia news and investor relations management, focusing on delivering actionable business and finance news to a global audience [1][2] - The company has a strong presence in key financial hubs, including London, New York, Toronto, Vancouver, Sydney, and Perth, and specializes in medium and small-cap markets while also covering blue-chip companies and broader investment stories [2][3] - Proactive's news coverage includes various sectors such as biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] Group 2 - The company is committed to adopting advanced technologies to enhance its content creation and workflow processes, leveraging decades of expertise from its team [4] - Proactive utilizes automation and software tools, including generative AI, while ensuring that all published content is edited and authored by humans to maintain quality and best practices [5]
NanoViricides commissions animal study of broad-spectrum antiviral for measles
Proactiveinvestors NA· 2025-06-04 13:03
Company Overview - Proactive is a financial news publisher that provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2] - The company has a team of experienced and qualified news journalists who produce independent content [2] Market Focus - Proactive specializes in medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [3] - The content includes insights across various sectors such as biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] Technology Adoption - Proactive is recognized for being a forward-looking technology adopter, utilizing technologies to enhance workflows [4] - The company employs automation and software tools, including generative AI, while ensuring that all content is edited and authored by humans [5]